| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Bone Diseases, Metabolic | D001851 | 9 associated lipids |
Total
2
cladrin
cladrin is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 53 references associated with cladrin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for cladrin
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with cladrin
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with cladrin
Download all related citationsTotal
9
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rashid M et al. | Development and validation of UPLC-MS/MS assay for quantification of cladrin: Absolute bioavailability and dose proportionality study in rats. | 2018 | J Pharm Biomed Anal | pmid:29454264 |
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Singh S et al. | Study of conformational stability, structural, electronic and charge transfer properties of cladrin using vibrational spectroscopy and DFT calculations. | 2014 | Spectrochim Acta A Mol Biomol Spectrosc | pmid:24892542 |
| Khan K et al. | Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation. | 2013 | Osteoporos Int | pmid:22932734 |
| Gautam AK et al. | Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats. | 2011 | J. Nutr. Biochem. | pmid:20579866 |
| Lee S et al. | Isoflavone derivatives inhibit NF-κB-dependent transcriptional activity. | 2010 | Bioorg. Med. Chem. Lett. | pmid:20829041 |
| Crombie L and Whiting DA | Review article number 135 biosynthesis in the rotenoid group of natural products: applications of isotope methodology. | 1998 | Phytochemistry | pmid:11711058 |
| Pandey R et al. | Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction. | Menopause | pmid:20395887 | |
| pmid: |